Welcome to the e-CCO Library!

DOP11 Normalisation of faecal calprotectin within 12 months of diagnosis is associated with a reduced risk of disease progression in Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

N. Plevris, J. Fulforth, P. Jenkinson, M. Lyons, C. Chuah, S. Siakavellas, R. Pattenden, I. Arnott, G. Jones, C. Lees

Created: Thursday, 30 January 2020, 10:12 AM
DOP11: A novel diagnostic serum protein signature for paediatric Inflammatory Bowel Disease: A discovery and validation study in two independent inception cohorts
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Bache-Wiig Mathisen, C.(1,2)*;Nyström, N.(3);Bazov, I.(4);Andersen, S.(5);Olbjørn, C.(6);Perminow, G.(7);Kristensen, V.A.(1,8);Opheim, R.(1,9);Ricanek, P.(10,11);D`Amato, M.(12,13,14);Carlson, M.(15);Hedin, C.R.(16,17);Keita, Å.V.(18);Kruse, R.(19);Lindqvist, C.M.(20);Magnusson, M.K.(21);Salihovic, S.(22,23);Söderholm, J.D.(18);Öhman, L.(21);Repsilber, D.(4);Høivik, M.L.(1,2);Halfvarson, J.(24);
Created: Friday, 14 July 2023, 10:43 AM
DOP11: Early intestinal ultrasound predicts endoscopic response to anti-inflammatory treatment and shows drug-specific response to biologicals and tofacitinib in Ulcerative Colitis
Year: 2022
Source: ECCO'22
Authors: de Voogd, F.(1);Bots, S.(1);Van Wassenaer, E.(2);De Jong, M.(1);Pruijt, M.(1);Löwenberg, M.(1);D'Haens, G.(1);Gecse, K.(1);
Created: Friday, 11 February 2022, 3:52 PM
DOP11: Fibrosis and MAGNIFI-CD activity-index at MRI to predict treatment outcome in perianal fistulising Crohn’s Disease patients
Year: 2021
Source: ECCO'21 Virtual
Authors: Van Rijn, K.(1);Meima-van Praag, E.(2);Bossuyt, P.(3);D'Haens, G.(4);Horsthuis, K.(5);Snijder, H.(2);Tielbeek, J.(1);Buskens, C.(2);Stoker, J.(1)
Created: Wednesday, 2 June 2021, 4:12 PM
DOP11: Lymphocyte activation gene (LAG)-3 on T cells is a potential therapeutic target in ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Slevin*1, M. Tan1, C. Lahiff1, L. M. Wang2, B. Greenaway1, K. Lynch1, A. Geremia1, S. Hughes3, K. Leavens3, K. Nevin3, D. J. B. Marks3, R. Tarzi3, N. Srinivasan3, S. Travis1, C. Arancibia1, S. Keshav1

Created: Friday, 22 February 2019, 9:41 AM
DOP12 Efficacy of ustekinumab for ulcerative colitis through 2 years: Results of the UNIFI maintenance study and long-term extension
Year: 2020
Source:

ECCO'20 Vienna

Authors:

R. Panaccione1, W.J. Sandborn2, B.E. Sands3, C. Marano4, C.D. O’Brien4, H. Zhang5, J. Johanns5, Y. Zhou5, L. Peyrin-Biroulet6, T. Hisamatsu7, S. Danese8, UNIFI Investigators

Created: Thursday, 30 January 2020, 10:12 AM
DOP12: Mutations in the X-linked inhibitor of apoptosis protein promote susceptibility to microbiota-induced intestinal inflammation
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Gopalakrishnan1,2, Y. Zeissig2, A. Strigli1, M. Basic3, J. Hartwig2, J. Wang4, M. Muders5, G. Barreton5, J. F. Baines4, A. Bleich3, J. Hampe1,5, S. Zeissig*1,2,5

Created: Friday, 22 February 2019, 9:41 AM
DOP12: Non-invasive assessment of intestinal inflammatory activity in Ulcerative Colitis by Multispectral Optoacoustic Tomography (MSOT)
Year: 2022
Source: ECCO'22
Authors: Klett, D.(1);Jesper, D.(1);Vitali, F.(1);Federle, A.(1);Atreya, R.(1);Strobel, D.(1);Leppkes, M.(1);Neufert, C.(1);Rath, T.(1);Neurath, M.F.(1);Waldner, M.J.(1);
Created: Friday, 11 February 2022, 3:52 PM
DOP12: Validation of a modified simple ultrasound activity Score for children with Crohn’s Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Ma, H.(1);Isaac, D.M.(1);Petrova, A.(1);Almeida, P.(1);Parsons, D.(1);Kuc, A.(1);Carroll, M.W.(1);Wine, E.(1);HuynhDr, H.(2)
Created: Wednesday, 2 June 2021, 4:12 PM
DOP12: Validation of radiomics features on MR enterography characterizing inflammation and fibrosis in stricturing Crohn's disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Sleiman, J.(1)*;Chirra, P.(2);Gandhi, N.(3);Gordon, I.O.(4);Viswanath, S.(2);Rieder, F.(5,6);
Created: Friday, 14 July 2023, 10:43 AM
DOP13 Clinical and endoscopic response to ustekinumab in Crohn’s disease: Week 16 interim analysis of the STARDUST trial
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Danese1, S. Vermeire2, G. D’Haens3, J. Panés4, A. Dignass5, F. Magro6, M. Nazar7, M. Le Bars8, S. Sloan9, M. Lahaye10, L. Ni11, M. Daperno12, M. Lukáš13, A. Armuzzi14, M. Löwenberg3, D.R. Gaya15, L. Peyrin-Biroulet16

Created: Thursday, 30 January 2020, 10:12 AM
DOP13: Artificial Intelligence (AI) in endoscopy - Deep learning for detection and scoring of Ulcerative Colitis (UC) disease activity under multiple scoring systems
Year: 2021
Source: ECCO'21 Virtual
Authors: Byrne, M.(1);East, J.(2);Iacucci, M.(3);Panaccione, R.(4);Kalapala, R.(5);Duvvur, N.(5);Rughwani, H.(5);Singh, A.(5);Henkel, M.(6);Canaran, L.(7);Laage, G.(7);St-Denis, L.(7);Nikfal, S.(7);Asselin, J.(7);Monsurate, R.(8);Cremonese, E.(7);Soudan, F.(7);Travis, S.(9)
Created: Wednesday, 2 June 2021, 4:12 PM
DOP13: Immune profiling of adipose tissue in murine models of inflammatory bowel disease (IBD)
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Letizia*1, Y. Rodriguez Sillke1, F. Schmidt1, C. Günther2, D. Kunkel3, R. Glauben1, B. Siegmund1, C. Weidinger1

Created: Friday, 22 February 2019, 9:41 AM
DOP13: Plasma metabolite fingerprint could discriminate inflammatory bowel disease patients from healthy subjects
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Farkas, K.(1)*;Endre, G.(2);Bacsur, P.(1);Resál, T.(1);Kocsmárszky-Koósz, V.(2);Tömösi, F.(2);Tóth, E.(2);Rutka, M.(1);Bálint, A.(1);Fábián, A.(1);Bor, R.(1);Szepes, Z.(1);Goretity, Á.(2);Thibodeau, I.(2);Molnár, T.(1);
Created: Friday, 14 July 2023, 10:43 AM
DOP13: The Arborisation index: An MRI-based measure of mesenteric hyperaemia in Crohn’s Disease
Year: 2022
Source: ECCO'22
Authors: Naim, I.(1,2);Darie, A.M.(1,2);Hoad, C.(2,3);Gowland, P.(2,3);Moran, G.W.(1,2);
Created: Friday, 11 February 2022, 3:52 PM
DOP14 Modelling of the relationship between infliximab exposure, faecal calprotectin, and endoscopic remission in patients with Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E. Dreesen1, S. Berends2, D. Laharie3, G. D’Haens4, S. Vermeire5, A. Gils1, R. Mathôt2

Created: Thursday, 30 January 2020, 10:12 AM
DOP14: Identification and validation of a lipidomic signature as a novel diagnostic biomarker of paediatric Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Salihovic, S.(1);Nyström, N.(2)*;Bache-Wiig Mathisen, C.(3);Andersen, S.(4);Olbjørn, C.(5);Perminow, G.(6);Opheim, R.(7);Detlie, T.E.(8);Huppertz-Hauss, G.(9);Bazov, I.(1);Kruse, R.(10);Lindqvist, C.M.(1);Hedin, C.R.H.(11);Carlson, M.(12);Öhman, L.(13);Magnusson, M.(13);Keita, Å.V.(14);Söderholm, J.D.(14);D'Amato, M.(15);Orešič, M.(1);Repsilber, D.(1);Hyötyläinen, T.(16);Hoivik, M.L.(3);Halfvarson, J.(17);
Created: Friday, 14 July 2023, 10:43 AM
DOP14: TiO2 nanoparticles abrogate the protective effect of the autoimmunity-associated PTPN22R619W variant during acute DSS colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Schwarzfischer*1, L. Hering1, E. Katkeviciute1, A. Niechcial1, K. Atrott1, K. Bäbler1, P. Busenhart1, G. Rogler1, M. Scharl1, M. Spalinger1

Created: Friday, 22 February 2019, 9:41 AM
DOP14: Ultra-high magnification endocytoscopy and molecular markers for defining endoscopic and histologic remission in Ulcerative Colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Iacucci, M.(1,2,3);Nardone, O.M.(1);Jeffery, L.(1);Acharjee, A.(4);Zardo, D.(5);Smith, S.C.(1);Bazarova, A.(6);Cannatelli, R.(1);Shivaji, U.N.(1);Williams, J.(4);Georgios, G.(4);Ghosh, S.(1,2,3)
Created: Wednesday, 2 June 2021, 4:12 PM
DOP14: Validation of a new OPtical diagnosis Training platform to Improve dysplasia Characterisation in Inflammatory Bowel Disease (OPTIC-IBD): A multicentre randomised controlled study
Year: 2022
Source: ECCO'22
Authors: Iacucci , M.(1,2);Ingram , R.J.M.(1,2);Bazarova , A.(3);Cannatelli , R.(4);Labarile , N.(5);Nardone , O.M.(6);Parigi , T.L.(1,7);Siau , K.(8);Smith , S.C.L.(1);Ferraz , J.G.P.(2);Kiesslich , R.(9);Panaccione , R.(2);Parra-Blanco , A.(10);Tontini , G.E.(11,12);Uraoka , T.(13);Ghosh , S.(14);
Created: Friday, 11 February 2022, 3:52 PM